title: A novel component different from endotoxin extracted from Prevotella intermedia ATCC 25611 activates lymphoid cells from C3H/HeJ mice and gingival fibroblasts from humans.
abstract: A novel immunobiologically active fraction was prepared from a phenol-water extract of Prevotella intermedia ATCC 25611 by Sephadex G-100 column chromatography. The fraction consisted mainly of carbohydrate and protein and was devoid of fatty acid. The fraction showed high-molecular-weight bands (10,000 to 12,000) on deoxycholate polyacrylamide gel electrophoresis (DOC-PAGE) and was scarcely active in a Limulus test. We designated the fraction Prevotella glycoprotein (PGP). The PGP fraction showed strong mitogenicity on splenocytes and cytokine-inducing activities on peritoneal macrophages from both C3H/HeJ and C3H/HeN mice, and it stimulated human gingival fibroblasts to produce cytokines. The activities of the PGP fraction were resistant to heat inactivation (100 degrees C for 1 h) and protease treatments and were scarcely inhibited by polymyxin B. In contrast, the purified lipopolysaccharide fraction (LPS-PCP) extracted from the same bacterium with a phenol-chloroform-petroleum ether mixture, which showed strong Limulus activity and a single low-molecular-weight band (approximately 3,000) on DOC-PAGE, lacked the activities on splenocytes and macrophages from C3H/HeJ mice and human gingival fibroblasts. The activities of the LPS-PCP fraction on cells from C3H/HeN mice were completely inhibited by polymyxin B. The LPS extracted from the same bacterium with hot phenol-water (LPS-PW) exhibited the properties of both the PGP fraction and the LPS-PCP fraction. These findings suggest that the unique bioactivities of the LPS-PW fraction of oral black-pigmented bacteria reported to date, which differed from those of the classical endotoxin, were derived from the PGP fraction and not from the LPS itself.
authors.affiliation: Department of Microbiology and Immunology, Kagoshima University Dental School, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Iki
authors.forename: K
authors.initials: K
authors.lastname: Kawahara
authors.forename: S
authors.initials: S
authors.lastname: Sawamura
authors.forename: R
authors.initials: R
authors.lastname: Arakaki
authors.forename: T
authors.initials: T
authors.lastname: Sakuta
authors.forename: A
authors.initials: A
authors.lastname: Sugiyama
authors.forename: H
authors.initials: H
authors.lastname: Tamura
authors.forename: T
authors.initials: T
authors.lastname: Sueda
authors.forename: S
authors.initials: S
authors.lastname: Hamada
authors.forename: H
authors.initials: H
authors.lastname: Takada
mesh_terms: D000276:Adjuvants, Immunologic / Q000032:analysis*; D000818:Animals; D016207:Cytokines / Q000096:biosynthesis; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D005881:Gingiva / Q000166:cytology; D006023:Glycoproteins / Q000032:analysis* / Q000494:pharmacology; D006801:Humans; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation; D051379:Mice; D008809:Mice, Inbred C3H; D011112:Polymyxin B / Q000494:pharmacology; D018713:Prevotella intermedia / Q000737:chemistry*
chemical_list: D000276:Adjuvants, Immunologic; D016207:Cytokines; D006023:Glycoproteins; D008070:Lipopolysaccharides; D011112:Polymyxin B